Sugammadex Use in a Patient with Wolff-Parkinson-White (WPW) Syndrome
Yükleniyor...
Dosyalar
Tarih
2015
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Background: Wolff-Parkinson-White (WPW) syndrome is a disease associated with episodes of supra- ventricular tachycardia and ventricular pre-excitation or atrial fibrillation. WPW is characterized by an aber- rant electrical conduction pathway between atria and ventricles. Case Report: The major anesthetic problem connected with WPW syndrome is the risk of tachyarrhythmias due to accessory pathway. Therefore, it has been pro- posed that the aim of anesthetic management should be the avoidance of tachyarrhythmia and sympathetic stimulation. Sugammadex was administered as a neu- romuscular reversal agent in this case. To our knowl- edge, this is the first case report of sugammadex use in a patient with WPW. This report presents a case of general anesthesia management in a patient with WPW syndrome. Conclusion: We think that it is appropriate to use su- gammadex to reverse rocuronium for the prevention of sudden hemodynamic changes in patients with WPW who underwent general anesthesia.
Açıklama
Anahtar Kelimeler
Cerrahi
Kaynak
Balkan Medical Journal
WoS Q Değeri
Q4
Scopus Q Değeri
Cilt
32
Sayı
3
